In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ...

While many people are familiar with mammograms and smear tests, prostate screening is talked about far less.To shed light on this important subject ahead of Prostate Cancer Awareness Month in March, ...

The average age of men who get diagnosed is 67.

Scientists at NYU Langone Health examined cancerous and benign tissues from 10 patients with prostate cancer and found “small ...

A new study released Tuesday found microplastics deep inside samples from 9 out of 10 patients with prostate cancer, with more microplastic levels inside tumors than in regular healthy tissue nearby.

Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

Microplastics have now been found inside most prostate cancer tumors — and at strikingly higher levels than in healthy tissue.

The Alabama House on Tuesday passed two bills that would eliminate cost sharing for certain types of breast and prostate ...

Astellas is aiding Vir Biotechnology’s oncology pivot with a $1.7 billion global collaboration focused on a potential best-in-class T-cell engager (TCE) for prostate cancer. | Astellas is aiding Vir ...

Actinium-225 is a targeted and highly-potent alpha emitter that holds promise for patients who do not respond to lutetium-177 ...

Bayer sued Johnson and Johnson, alleging false advertising for its prostate cancer drug Erleada, claiming it misleads patients.

Bayer filed a lawsuit against Johnson & Johnson and its Janssen Biotech unit, alleging that marketing claims regarding the superiority of J&J's Erleada prostate-cancer drug versus Bayer's Nubeqa are ...